Investigation of Delafloxacin Resistance in Multidrug-Resistant <i>Escherichia coli</i> Strains and the Detection of <i>E. coli</i> ST43 International High-Risk Clone

Delafloxacin is a novel fluoroquinolone agent that is approved for clinical application. In this study, we analyzed the antibacterial efficacy of delafloxacin in a collection of 47 <i>Escherichia coli</i> strains. Antimicrobial susceptibility testing was performed by the broth microdilution method a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dániel Gulyás, Katalin Kamotsay, Dóra Szabó, Béla Kocsis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-06-01
coleção:	Microorganisms
Assuntos:	fluoroquinolones delafloxacin multidrug-resistance extended-spectrum beta-lactamase <i>E. coli</i>
Acesso em linha:	https://www.mdpi.com/2076-2607/11/6/1602
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!